Nuermberger, Eric L <br/><br/>
Moxifloxacin-containing regimens of reduced duration produce a stable cure in murine tuberculosis.  [electronic resource] 

 -  American journal of respiratory and critical care medicine  Nov 2004 
 - 1131-4 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>1073-449X 
<br/><br/><label>Standard No.: </label>10.1164/rccm.200407-885OC  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antitubercular Agents--pharmacology<br/>Aza Compounds--pharmacology<br/>Disease Models, Animal<br/>Dose-Response Relationship, Drug<br/>Drug Administration Schedule<br/>Drug Therapy, Combination<br/>Female<br/>Fluoroquinolones<br/>Mice<br/>Mice, Inbred BALB C<br/>Moxifloxacin<br/>Multivariate Analysis<br/>Quinolines--pharmacology<br/>Random Allocation<br/>Reference Values<br/>Sensitivity and Specificity<br/>Tuberculosis, Pulmonary--drug therapy